Sonic Hedgehog Medulloblastoma Cells in Co-culture with Cerebellar Organoids
Source van Essen et al., 2025 · Nuffield Department of Clinical Neurosciences, University of Oxford Medical Sciences Division · 10.1093/noajnl/vdae218
Abstract
This protocol describes the differentiation of human iPSC-derived cerebellar organoids and their co-culture with sonic hedgehog medulloblastoma (SHH-MB) cell lines to model the tumor microenvironment. The co-culture system allows investigation of how the nonmalignant microenvironment regulates malignant cell states and transcriptional phenotypes using single-cell RNA sequencing.
Protocol overview
28 steps across 5 phases
- 1 iPSC Dissociation and Cell Preparation
- 2 Plating of Organoid Initiation
- 3 FGF2 Supplementation
- 4 Medium Change at Day 7
- 5 Full Medium Change and Transfer at Day 14
- 6 Switch to Differentiation Medium at Day 21
- 7 Full Medium Changes at Days 28 and 35
- 8 Maintenance Beyond Day 35
- 1 DAOY Cell Line Maintenance
- 2 ONS-76 Cell Line Maintenance
- 3 Tumor Spheroid Generation from DAOY and ONS-76
- 4 Spheroid Maturation
- 1 Co-culture Initiation (Day 35 Organoid + Day 7 Spheroid)
- 2 Facilitate Fusion by Angled Incubation
- 3 Co-culture Maintenance (Days 2–25)
- 4 Parallel Controls
- 1 Harvest Co-culture Samples
- 2 Enzymatic Dissociation of Organoids
- 3 Wash and Trituration of Organoids
- 4 Dead Cell Removal
- 5 Cell Viability Assessment and Counting
- 6 Resuspension in Sequencing Buffer
- 7 Enzymatic Dissociation of Tumor Spheroid Monocultures
- 8 Processing of Tumor Spheroid Cells
- 9 Processing of Monolayer Cell Cultures
- 1 Single-Cell Barcoding and cDNA Synthesis
- 2 Library Preparation and Amplification
- 3 Illumina NovaSeq 6000 Sequencing
Full SOP
Create a free account to access this protocol
Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.
Create free accountAlready registered? Log in
Attribution
This SOP was authored by Organthis based on the published method in van Essen et al., 2025. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.
This wording is awaiting legal review.
Something wrong with this entry? Report an issue with this protocol